|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn774282603 |
003 |
OCoLC |
005 |
20231117044702.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
111228s2011 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OPELS
|d N$T
|d OCLCQ
|d OCLCF
|d YDXCP
|d CNSPO
|d UKDOC
|d UIU
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d OL$
|d UKBTH
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 872685345
|
020 |
|
|
|a 9780123870452
|q (electronic bk.)
|
020 |
|
|
|a 0123870453
|q (electronic bk.)
|
020 |
|
|
|z 9780123870445
|
020 |
|
|
|z 0123870445
|
035 |
|
|
|a (OCoLC)774282603
|z (OCoLC)872685345
|
050 |
|
4 |
|a QR41.2
|b .A38 2011eb
|
072 |
|
7 |
|a SCI
|x 008000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 579
|2 23
|
245 |
0 |
0 |
|a Advances in applied microbiology.
|n Volume 77 /
|c edited by Allen I. Laskin, Sima Sariaslani, Geoffrey M. Gadd.
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Amsterdam :
|b Elsevier/Academic Press,
|c 2011.
|
300 |
|
|
|a 1 online resource (viii, 154 pages) :
|b illustrations (some color).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in applied microbiology,
|x 0065-2164 ;
|v v. 77
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Published since 1959, Advances in Applied Microbiology continues to be one of the most widely read and authoritative review sources in microbiology. The series contains comprehensive reviews of the most current research in applied microbiology. Recent areas covered include bacterial diversity in the human gut, protozoan grazing of freshwater biofilms, metals in yeast fermentation processes and the interpretation of host-pathogen dialogue through microarrays. Eclectic volumes are supplemented by thematic volumes on various topics, including Archaea and sick building syndrome.
|
505 |
0 |
|
|a Front Cover; Advances in Applied Microbiology; Copyright; Contents; Contributors; Chapter 1: Phage Therapy Pharmacology: Calculating Phage Dosing; I. Introduction; II. Standard Antibacterial In Vitro Metrics; A. Minimum inhibitory concentration; B. Minimum bactericidal concentration; III. Killing Titer and MBC Calculation; A. Multiplicity of infection; B. MBC with constant phage density; C. MBC without constant phage density; D. Complete phage adsorption; E. Further comparison of MOIactual with MOIinput; F. Phage enhancement and limitations; G. Multiplicity of 10
|
505 |
8 |
|
|a IV. Reduction Times and DosingA. Decimal reduction time; B. Time until eradication; C. Frequency of phage dosing; V. Bacterial Density and Phage Population Growth; A. Proliferation threshold; B. Half-maximal phage population growth rate; C. Peak phage density; VI. Effective Dose Revisited; VII. Conclusion; Appendix. Impact of phage and bacterial densities on rates of bacterial eradication; References; Chapter 2: From R�io Tinto to Mars: The Terrestrial and Extraterrestrial Ecology of Acidophiles; I. Introduction; II. Extremophiles; III. Acidophiles; IV. Geomicrobiology of R�io Tinto
|
505 |
8 |
|
|a A. Water columnB. Sediments; C. Eukaryotes; V. Subsurface Geomicrobiology of the Iberian Pyrite Belt; VI. Methanogenesis in Nonmethanogenic Conditions; VII. R�io Tinto as a Geochemical Analogue of Mars; VIII. Future Trends; References; Chapter 3: Fungal Adaptation to Extremely High Salt Concentrations; I. Halotolerant and Halophilic Fungi: An Introduction; A. The challenges of hypersaline environments; B. Why study them?; II. Hortaea werneckii-A Model for Extreme Halotolerance; A. The compatible-solute strategy of Hortaea werneckii; B. The HOG signaling pathway in Hortaea werneckii
|
505 |
8 |
|
|a C. The importance of energy metabolism in Hortaea werneckiiIII. Wallemia ichthyophaga-Alternative Halophilic Solutions; IV. The Next Step: Genomics, Transcriptomics, and Beyond; V. Conclusions: An Integrated Model of Extreme Halotolerance; Acknowledgments; References; Chapter 4: Resistance of Yeasts to Weak Organic Acid Food Preservatives; I. The Monocarboxylate Preservatives; A. Safety concerns of the use of these monocarboxylate weak acid preservatives; B. The practical importance of understanding weak acid adaptation; II. The Physiological Action of Weak Organic Carboxylic Acids on Yeast
|
505 |
8 |
|
|a III. Resistance MechanismsA. Resistance through weak acid catabolism; B. Adaptation to high levels of acetic acid; 1. Hog1-mediated destabilization of Fps1 facilitates adaptation to acetic acid stress; 2. Altered gene expression facilitates adaptation to acetic acid stress; C. Overcoming the constant weak acid stress imposed on S. cerevisiae by the presence of moderately lipophilic organic acids...; 1. War1 may be activated by direct binding of the acid anion; 2. Pdr12-A weak acid efflux pump; D. Resistance by limiting diffusional entry of the acid; IV. Conclusions; References
|
650 |
|
0 |
|a Microbiology.
|
650 |
|
2 |
|a Microbiology
|0 (DNLM)D008829
|
650 |
|
6 |
|a Microbiologie.
|0 (CaQQLa)201-0003856
|
650 |
|
7 |
|a microbiology.
|2 aat
|0 (CStmoGRI)aat300054469
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biology.
|2 bisacsh
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Microbiology.
|2 bisacsh
|
650 |
|
7 |
|a Microbiology
|2 fast
|0 (OCoLC)fst01019576
|
700 |
1 |
|
|a Laskin, Allen I.,
|d 1928-
|
700 |
1 |
|
|a Sariaslani, Sima.
|
700 |
1 |
|
|a Gadd, Geoffrey M.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123870445
|z Texto completo
|